La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Fenrigrel Darisar
Country: Bahamas
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 25 September 2005
Pages: 251
PDF File Size: 1.38 Mb
ePub File Size: 3.74 Mb
ISBN: 776-1-47680-740-6
Downloads: 10347
Price: Free* [*Free Regsitration Required]
Uploader: Kigalar

However, it is not clear if this translates into clinical benefits. In general, it czbergolina recommended that fetal exposure to all drugs be limited to as short a period as possible. Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life.

Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, experience with bromocriptine is higher.

Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials.

In microprolactinomas the ophthalmologic examination is no formal indication. Primary medical therapy of micro- and macroprolactinomas in men. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma. The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea.


Su principal desarrollo cabeegolina la base de datos Epistemonikos www. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media.

De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. Sobre los desenlaces incluidos en este resumen. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. Cabergoline Comparative Study Group. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.

We combined the evidence using meta-analysis and generated a summary of findings following the GRADE approach. Todos los estudios compararon bromocriptina versus cabergolina.

In the absence of menstrual period, the drug should be discontinued and confirm pregnancy. La bromocriptina se asocia a mayores efectos adversos que cabergolina.

їCabergolina o bromocriptina para el prolactinoma? – Medwave

Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: Medwave se preocupa por su privacidad y la seguridad de sus datos personales.

Middle East Fertility Society Journal. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed. Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral. J Clin Endocrinol Metab. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: N Engl J Med.


Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma.

Dostinex y embarazo múltiple

There is evidence that breastfeeding no increased risk for tumor growth. Pakistan Journal of Medical Sciences Online. Cabergoline or bromocriptine for prolactinoma?.

Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. Results of a national multicenter randomized double-blind study].

[Update on endocrinology: management of prolactinomas during pregnancy].

The prolactinomas are the most common functioning pituitary tumors. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. The hyperprolactinemia is associated with anovulation and infertility. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. Diagnosis and treatment of yperprolactinemia: It is not clear whether cabergoline is also more effective with respect to tumor growth because the cabergolian of the evidence is very low.